Market Insights | Rx Property Australia

Why a Cold Shell May Not Be Leasable in the Current Market, and When to Consider a Spec Suite

Written by Bryce Stickland | Apr 7, 2026 4:45:07 PM

When a medical occupier starts looking at space, one of the first questions is usually, “What is the rent?” It sounds sensible. Rent is visible, easy to compare, and often treated as the headline number in a deal. But in medical leasing, that question can send tenants down the wrong path very quickly.

The better question is this: what is the real occupancy cost once the incentive structure, fitout requirements, lease term, make good risk, building capability, and relocation cost are properly accounted for?

Face rent on its own does not tell you whether a deal is competitive. In many healthcare transactions, especially where specialist use, patient flow, compliance, services capacity, and capital works matter, the commercial position is shaped by far more than the advertised rental rate.

Two suites can both be quoted at the same $/sqm figure and produce very different outcomes for a tenant. One might come with a meaningful fitout contribution, rent-free period, landlord works, upgraded services, signage flexibility, and a layout that reduces fitout waste. The other might offer a lower headline rent but require the occupier to carry substantial upfront capital, approval delays, and reconfiguration costs. On paper the cheaper deal can end up being the more expensive one.

This becomes even more important in medical leasing because the cost to occupy is not limited to rent. Many practices are not simply taking generic office space. They are dealing with hydraulic requirements, disability access, pathology or imaging interfaces, sterilisation needs, treatment room standards, acoustic separation, after-hours access, and landlord consent risk. Those issues have a direct commercial effect.

Incentives are often misunderstood in this process. Many occupiers assume there is a straight-line relationship between face rent and incentive level. In reality, there often is not. Incentives are driven by a range of factors including the landlord’s vacancy profile, asset positioning, term certainty, building competition, capital budget, tenant covenant, and whether the space is easy or difficult to re-lease later. A landlord may hold a firm face rent but increase contribution to works. Another may reduce face rent but offer little or no support on capital expenditure.

That distinction matters not just to tenants, but also to owners and valuers. When valuers assess whether an asset is under-rented or over-rented, they are not always looking at the headline number in isolation. If the market is producing inconsistent incentive outcomes, the face rent can be a poor proxy for the real deal. A lease struck at a strong nominal rent with a heavy package of incentives may not mean what it appears to mean at first glance. Likewise, a lower face rent with very limited incentive support may be commercially tighter than expected.

For medical occupiers, this is where poor comparisons become dangerous. If a tenant benchmarks deals only on asking rent, they can end up rejecting a workable opportunity that actually delivers better value over the lease term. They can also over-commit to a space that looks sharp on a brochure but requires too much tenant capital to make it operational.

A better process is to compare opportunities across six practical headings. First, look at net effective cost over the initial term. Second, identify landlord works and cash incentives separately, because they are not the same thing. Third, assess building suitability before fitout drawings begin. Fourth, price time risk, especially if approvals or building upgrades are required. Fifth, understand relocation disruption to patients, referrers, and staff. Sixth, consider exit risk and make good.

In the medical sector, time is often the hidden cost. A delayed move can mean extended holdover, duplicated rent, slower practitioner recruitment, and patient leakage during transition. That cost can easily outweigh a modest saving in face rent.

There is also a strategic point here for groups planning growth. Leasing should not be treated as a narrow procurement exercise where the goal is to shave a few dollars off the quoted rent. The better objective is to secure a site that supports revenue, clinical workflow, practitioner retention, and patient experience while preserving capital.

The right lease is rarely the one with the lowest advertised rent. It is the one where the total package fits the operating model and where the numbers still work after the real costs are laid out clearly.

So before asking, “What is the rent?”, medical occupiers should ask something more useful: what am I actually paying, what am I getting in return, and what risks am I taking on to make this space work?

That is the point where leasing analysis starts to become commercially useful.